These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 20171115)
1. Circadian variations of interleukin 6 in coronary circulations of patients with myocardial infarction. Bonda T; Kaminski KA; Kozuch M; Kozieradzka A; Wojtkowska I; Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Musial WJ Cytokine; 2010 May; 50(2):204-9. PubMed ID: 20171115 [TBL] [Abstract][Full Text] [Related]
2. Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction. Kaminski KA; Kozuch M; Bonda T; Wojtkowska I; Kozieradzka A; Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Winnicka MM; Musial WJ Atherosclerosis; 2009 Oct; 206(2):581-7. PubMed ID: 19406401 [TBL] [Abstract][Full Text] [Related]
3. Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction. Groot HE; Al Ali L; van der Horst ICC; Schurer RAJ; van der Werf HW; Lipsic E; van Veldhuisen DJ; Karper JC; van der Harst P Clin Res Cardiol; 2019 Jun; 108(6):612-621. PubMed ID: 30367209 [TBL] [Abstract][Full Text] [Related]
4. IL-6 and its receptors in coronary artery disease and acute myocardial infarction. Anderson DR; Poterucha JT; Mikuls TR; Duryee MJ; Garvin RP; Klassen LW; Shurmur SW; Thiele GM Cytokine; 2013 Jun; 62(3):395-400. PubMed ID: 23582716 [TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin 6 receptor levels are associated with reduced myocardial reperfusion after percutaneous coronary intervention for acute myocardial infarction. Groot HE; Hartman MH; Gu YL; de Smet BJ; van den Heuvel AF; Lipsic E; van der Harst P Cytokine; 2015 Jun; 73(2):207-12. PubMed ID: 25792278 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous coronary interventions affect concentrations of interleukin 6 and its soluble receptors in coronary sinus blood in patients with stable angina. Kaminski KA; Kozieradzka A; Bonda T; Banach M; Kozuch M; Wojtkowska I; Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Mikhailidis DP; Musial WJ Angiology; 2009; 60(3):322-8. PubMed ID: 19508977 [TBL] [Abstract][Full Text] [Related]
8. Cytokines in patients with ischaemic heart disease or myocardial infarction. Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P Kardiol Pol; 2003 Aug; 59(8):105-14. PubMed ID: 14560325 [TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053 [TBL] [Abstract][Full Text] [Related]
10. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction. Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472 [TBL] [Abstract][Full Text] [Related]
11. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385 [TBL] [Abstract][Full Text] [Related]
12. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Robinson M; Gray SR; Watson MS; Kennedy G; Hill A; Belch JJ; Nimmo MA Scand J Med Sci Sports; 2010 Apr; 20(2):282-90. PubMed ID: 19422646 [TBL] [Abstract][Full Text] [Related]
13. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention. Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510 [TBL] [Abstract][Full Text] [Related]
19. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness. Weiss TW; Arnesen H; Seljeflot I Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306 [TBL] [Abstract][Full Text] [Related]
20. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ; Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]